Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans

Clinical trial NCT00084630 · COMPLETED

Trial details

NCT number: NCT00084630
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Fibrosarcoma Dermatofibrosarcoma Protuberans Recurrent Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma

Start date: 2004-05-01
Primary completion: 2007-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.